Works matching Rachel Maddux

Results: 9

The Long-Term Stability of Early Maladaptive Schemas.
Published in:
Cognitive Therapy & Research, 2006, v. 30, n. 4, p. 515, doi. 10.1007/s10608-006-9015-z
By:
- Riso, Lawrence P.;
- Froman, Shoshana E.;
- Raouf, Mona;
- Gable, Phillip;
- Maddux, Rachel E.;
- Turini-Santorelli, Noëlle;
- Penna, Suzanne;
- Blandino, Jaime A.;
- Jacobs, Carli H.;
- Cherry, Melissa
Publication type:
Article
The effects of yoga on stress and psychological health among employees: an 8- and 16-week intervention study.
Published in:
2018
By:
- Maddux, Rachel E.;
- Daukantaité, Daiva;
- Tellhed, Una
Publication type:
journal article
The effects of celecoxib augmentation on cytokine levels in schizophrenia.
Published in:
International Journal of Neuropsychopharmacology, 2006, v. 9, n. 3, p. 343, doi. 10.1017/s1461145705005808
By:
- Catherine J. Bresee;
- Katia Delrahim;
- Rachel E. Maddux;
- Douglas Dolnak;
- Oliver Ahmadpour;
- Mark Hyman Rapaport
Publication type:
Article
Mood and Global Symptom Changes among Psychotherapy Clients with Depressive Personality.
Published in:
Depression Research & Treatment, 2012, p. 1, doi. 10.1155/2012/208435
By:
- Maddux, Rachel E.;
- Lundh, Lars-Gunnar
Publication type:
Article
The Swedish Depressive Personality Disorder Inventory: Psychometrics and clinical correlates from a DSM-IV and proposed DSM-5 perspective.
Published in:
Nordic Journal of Psychiatry, 2012, v. 66, n. 3, p. 167, doi. 10.3109/08039488.2011.611251
By:
- Maddux, Rachel E.;
- Lundh, Lars-Gunnar;
- Bäckström, Martin
Publication type:
Article
Five-week yin yoga-based interventions decreased plasma adrenomedullin and increased psychological health in stressed adults: A randomized controlled trial.
Published in:
PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0200518
By:
- Daukantaitė, Daiva;
- Tellhed, Una;
- Maddux, Rachel E.;
- Svensson, Thomas;
- Melander, Olle
Publication type:
Article
SARS‐CoV‐2 vaccination and infection in ozanimod‐treated participants with relapsing multiple sclerosis.
Published in:
Annals of Clinical & Translational Neurology, 2023, v. 10, n. 10, p. 1725, doi. 10.1002/acn3.51862
By:
- Cree, Bruce A. C.;
- Maddux, Rachel;
- Bar‐Or, Amit;
- Hartung, Hans‐Peter;
- Kaur, Amandeep;
- Brown, Elizabeth;
- Li, Yicong;
- Hu, Yanhua;
- Sheffield, James K.;
- Silva, Diego;
- Harris, Sarah
Publication type:
Article
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
Published in:
Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 2044, doi. 10.1007/s10620-024-08391-z
By:
- Harris, Sarah;
- Feagan, Brian G.;
- Hanauer, Stephen;
- Vermeire, Severine;
- Ghosh, Subrata;
- Yan, Jim;
- Wu, Chun;
- Hu, Yanhua;
- Maddux, Rachel;
- Wolf, Douglas C.;
- D'Haens, Geert
Publication type:
Article
(DMT15) Extended Serologic Responses to SARS-CoV-2 Vaccination in Healthy Volunteers and DAYBREAK Participants With Relapsing Multiple Sclerosis Receiving Ozanimod.
Published in:
International Journal of MS Care, 2024, v. 26, p. 30
By:
- Cree, Bruce A. C.;
- Maddux, Rachel;
- Bar-Or, Amit;
- Hartung, Hans-Peter;
- Kaur, Amandeep;
- Yicong Li;
- Kai Fu;
- Yanhua Hu;
- Sheffield, James K.;
- Harris, Sarah
Publication type:
Article